English | Español
Patient Daily | Feb 9, 2026

FARE urges further action after Congress passes PBM reform affecting epinephrine access
Patient Daily | Feb 9, 2026

FDA faces major leadership turnover and regulatory shifts following Trump administration actions
Patient Daily | Feb 8, 2026

AstraZeneca acquires full rights to AbelZeta’s cancer therapy for $630 million
Patient Daily | Feb 8, 2026

GSK acquires RAPT Therapeutics for $2.2B under new CEO Luke Miels
Patient Daily | Feb 8, 2026

Biohaven outlines new strategy after setbacks and prepares muscle-sparing drug study
Patient Daily | Feb 8, 2026

CDMOs look to FDA's PreCheck program for support at new US production sites
Patient Daily | Feb 8, 2026

Penn Medicine earns national recognition for top clinical research achievements
Patient Daily | Feb 8, 2026

ACAAI offers guidance for an allergy-safe Valentine’s Day

Trending
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug
+ Pharmaceuticals
Patient Daily | Mar 19, 2026

BioSpace releases 2026 U.S. Life Sciences Salary Report with compensation insights